Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Parkinson's Disease
Trial Locations (13)

14467

RECRUITING

Klinikum Ernst von Bergmann /ID# 274176, Potsdam

35043

RECRUITING

Universitaetskliniken Giessen und Marburg /ID# 274224, Marburg

46242

RECRUITING

Knappschaftskrankenhaus Bottrop /ID# 274284, Bottrop

50668

NOT_YET_RECRUITING

Cellitinnen-NTC Neurologisches Therapiecentrum /ID# 277865, Cologne

69120

RECRUITING

Universitaetsklinikum Heidelberg /ID# 274164, Heidelberg

72076

RECRUITING

Universitaetsklinikum Tuebingen /ID# 275828, Tübingen

77709

RECRUITING

Parkinson-Klinik Ortenau GmbH&Co KG /ID# 274161, Wolfach

81337

NOT_YET_RECRUITING

Klinikum der Universitaet Muenchen Grosshadern /ID# 274168, Munich

89073

RECRUITING

Praxis Prof. Kassubek/Prof. Riecker /ID# 274165, Ulm

01307

RECRUITING

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 274167, Dresden

06120

RECRUITING

Krankenhaus Martha-Maria Halle-Dölau /ID# 274174, Halle

07551

RECRUITING

Praxis MD Oehlwein /ID# 274222, Gera

07646

RECRUITING

Asklepios Fachklinikum Stadtroda /ID# 274162, Stadtroda

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY